consultantcy fees, page-13

All,

To answer a few of the questions :

ewere - sorry but we spent a long time discussing the commercialisation strategy that the issue of stock/dating didn't come up (in that I didn't raise it). With the end of the financial year approaching we should know soon enough.For me its of strategic importance (although I acknowledge its short term impact)

Deltafive : Never say never, but (and again this is my opinion only based on where they and my personal experience) we should make it within the 210 day window and I don't anticipate there will be any further questions at this point.

Thymus: I actually have a reasonable holding, and have accumulated based on my confidence is this product to hit at least 500 000 000 over a 5 year window post launch.I did buy more after my discussion, however my sentiment is hold as I don't want to unduly influence people who are taking risks that they perhaps shouldn't. But I personally wouldn't encourage anyone to sell at the moment if you have a long term view on this stock it should/will pay off handsomely.

The bottom line is that there is still a lot to be proven in terms of the implementation - so there is still a high degree of speculation , however this is merely an issue based on the people factor (which can always change if things don't go according to plan).However I do strongly believe the product is great and the CE process should not throw up any surprises from here on in. As well the commercialisation plan is sensible and well conceived (in my opinion) , therefore the only speculative element is the implementation of the commercialisation process, everything else is pretty much where it should be.

Personally like all of us here i am not in the business of throwing good money away (and this holding is 100's of 1000's of dollars), and therefore I am extremely diligent with all my holdings and only invest in areas I understand (such as Pharma/Biotech/Life sciences).Based on that TIS has an acceptable risk profile for me to continue to hold and accumulate.